Skip to main content

February 2017 Vol 10, No 1

David B. Nash, MD, MBA
Kumar Mukherjee, PhD; Khalid M. Kamal, PhD
Understanding Patients’ Demographics Is Key to Improving Clinical and Economic Healthcare Outcomes
F. Randy Vogenberg, RPh, PhD
Stanton R. Mehr
Christopher B. Atzinger, MS, PhD candidate; Jeff J. Guo, BPharm, PhD
Rheumatoid Arthritis, Biologic Drugs, and Associated Cost
Byron C. Scott, MD, MBA
John Santilli, MBA, and F. Randy Vogenberg, RPh, PhD
Joseph Lee, PhD; Ryan Pelkey, MS; Julieanna Gubitosa, BS; Michael F. Henrick, MBA; Michael L. Ganz, MS, PhD
Identifying the Most Clinically and Economically Effective Therapies for Rheumatoid Arthritis Remains a Challenge for Providers and Payers
Gary Branning, MBA

Results 1 - 6 of 6